Use of Abelmoschi corolla extract in preparation of drug for treating fibrosis
Provided is the use of an Abelmoschi corolla extract in the preparation of a drug for treating fibrosis, wherein the extract contains at least 15% of gossypetin-3-O-β-D-glucose-8-O-β-D-glucuronide, with same being prepared by means of the following method: taking medicinal materials of Abelmoschi corolla , heating same with ethanol and performing reflux extraction, performing filtration, concentrating the filtrate, and carrying out macroporous resin column chromatography, where same is firstly washed with water, then eluting same with 3-7% of ethanol, eluting same with 9-15% of ethanol, and collecting 9-15% of an ethanol eluent in order to obtain the Abelmoschi corolla extract.
1. An herbal extract for treating fibrosis comprising at least 15% of gossypetin-3-O-β-D-glucose-8-O-β-D-glucuronide and acortatarin A by weight, wherein the herbal extract is prepared by the following steps: taking an herbal, carrying out ethanol heating reflux extraction of the herbal, filtering, concentrating a filtrate, carrying out macroporous resin column chromatography, washing the column with water first, then eluting the column with 3% to 7% ethanol, then eluting the column with 9% to 15% ethanol, and collecting a 9% to 15% ethanol eluate in order to obtain the herbal extract; wherein the ethanol is 50% to 95% in the step of ethanol heating reflux extraction.
2. The herbal extract according to claim 1 , wherein the herbal extract comprises 20% to 95% of gossypetin-3-O-β-D-glucose-8-O-β-D-glucuronide and acortatarin A by weight; wherein the herbal is a Hibiscus or a Malvaceae.
3. The herbal extract according to claim 2 , wherein the herbal extract is prepared as a drug for treating fibrosis; wherein the herbal extract is extracted from abelmoschi corolla, and comprises at least 15% of gossypetin-3-O-β-D-glucose-8-O-β-D-glucuronide and acortatarin A by weight; wherein the abelmoschi corolla is a dried corolla of Abelmoschus Manihot.
4. The herbal extract according to claim 3 , wherein the herbal extract comprises 20% to 95% of gossypetin-3-O-β-D-glucose-8-O-β-D-glucuronide and acortatarin A by weight.
5. The herbal extract according to claim 3 , wherein the ethanol is 80% to 95% in the step of ethanol heating reflux extraction; and the ethanol is 10% in the step of the eluting the column with 9% to 15% ethanol.
6. The herbal extract according to claim 2 , wherein the herbal extract comprises 30% to 80% of gossypetin-3-O-β-D-glucose-8-O-β-D-glucuronide and acortatarin A by weight; wherein the herbal is one or more selected from the group consisting of Abelmoschus manihot, Hibiseu manihot, Hibiscus vitifolius, Abelmoschus esculentus and Abutilon indicum.
7. The herbal extract according to claim 6 , wherein the herbal extract comprising 40% to 70% of gossypetin-3-O-β-D-glucose-8-O-β-D-glucuronide and acortatarin A by weight.
8. The herbal extract according to claim 4 , wherein the herbal extract comprises 40% to 70% of gossypetin-3-O-β-D-glucose-8-O-β-D-glucuronide and acortatarin A by weight.
9. The herbal extract according to claim 1 , wherein the fibrosis is selected from the group consisting of pulmonary fibrosis, liver fibrosis and renal fibrosis, wherein the renal fibrosis is from chronic kidney disease or diabetic nephropathy.
10. The herbal extract according to claim 1 , wherein the macroporous resin column chromatography sequentially comprises: washing the column with water, eluting the column with 5% ethanol, and eluting the column with 10% ethanol, wherein an elution dosage for gradient elution of each solvent is 3 bed volumes to 7 bed volumes.
11. The herbal extract according to claim 1 , wherein the herbal extract is prepared by the following steps: carrying out reflux extraction on abelmoschi corolla with 85% to 95% ethanol for one to three times, with each time lasting for one to two hours, filtering, combining filtrates and recovering ethanol, concentrating the filtrate to a specific gravity of 1.20 to 1.35, standing the concentrated solution at 0° C. to 4° C. for 24 hours to 48 hours to obtain a refrigerated solution, removing an oil layer of the refrigerated solution, adjusting the pH value to 6.0 to 7.0, concentrating, carrying out macroporous resin column chromatography by eluting the column with 5 bed volumes of pure water, 5 bed volumes of 5% ethanol and 7 bed volumes of 10% ethanol sequentially, and collecting a 10% ethanol elution fraction in order to obtain the herbal extract.
12. An abelmoschi corolla extract for treating renal fibrosis, comprising at least 15% of gossypetin-3-O-β-D-glucose-8-O-β-D-glucuronide and acortatarin A by weight; wherein the abelmoschi corolla extract is prepared by the following method: taking abelmoschi corolla, carrying out ethanol heating reflux extraction, filtering, concentrating the filtrate, carrying out macroporous resin column chromatography, washing the column with water, eluting the column with 5% ethanol, eluting the column with 10% ethanol, and eluting the column with 15% ethanol sequentially, and collecting 15% ethanol eluate and concentrating to obtain the abelmoschi corolla extract; wherein the abelmoschi corolla is a dried corolla of Abelmoschus Manihot.
13. The abelmoschi corolla extract according to claim 12 , wherein the ethanol is 50% to 95% in the step of the ethanol heating reflux.
14. The abelmoschi corolla extract according to claim 12 , wherein the abelmoschi corolla extract comprises 20% to 95% of gossypetin-3-O-β-D-glucose-8-O-β-D-glucuronide and acortatarin A by weight.
15. The abelmoschi corolla extract according to claim 14 , wherein the abelmoschi corolla extract comprises 40% to 70% of gossypetin-3-O-β-D-glucose-8-O-β-D-glucuronide and acortatarin A by weight.
16. The abelmoschi corolla extract according to claim 13 , wherein the ethanol is 80% to 95% in the step of the ethanol heating reflux.
17. The abelmoschi corolla extract according to claim 12 , wherein the fibrosis is selected from the group consisting of pulmonary fibrosis, liver fibrosis and renal fibrosis, wherein the renal fibrosis is from chronic kidney disease or diabetic nephropathy.